News

Cuba Moves Closer To Our Own COVID-19 Vaccine — Report

KUALA LUMPUR, Aug 21  – Leading enterprise group in Cuba’s biotechnology and pharmaceutical industry BioCubaFarma reports having received permission to begin clinical trials of a Cuban candidate vaccine to prevent COVID-19, capable of producing a strong immune reaction to a SARS-CoV-2 infection.

Identified as FINLAY-FR-1, the vaccine project led by the Finlay Vaccine Institute, the Centre for Molecular Immunology – both affiliated with BioCubaFarma – with the collaboration of the University of Havana’s Chemical and Biomolecular Synthesis Laboratory, has satisfactorily concluded the drug’s development stage and pre-clinical studies in animals, producing the scientific findings required to support authorisation, by Cuba’s Centre for State Control of Medications, Medical Equipment and Devices (Cecmed), to conduct clinical trials.

The announcement explained that this license allows for joint work with different institutions affiliated with the Ministry of Public Health to begin at this time, initiating “the clinical trial phase I-II, known as Sovereign, which will be followed by other clinical studies, before the vaccine is considered ready for use.”

“BioCubaFarma also reported that an industrial production strategy is being developed to build capacity with the goal of “having available the millions of doses needed to protect our population,” once the studies are concluded,” according to the report in Granma, the official newspaper of the Central Committee of the Cuban Communist Party, which was made available to Bernama by the Cuban Embassy in Malaysia.

Also of special interest is the fact reported that Cuba’s candidate vaccine is the 30th – the first in Latin America and the Caribbean – to receive authorisation for clinical trials, among the more than 200 under development around the world.

The Finlay Vaccine Institute, which submitted the license application, has more than 30 years of experience in developing vaccines, the announcement notes, stating, “The fact that the Institute has available platforms developed for other epidemics, specifically that developed for the meningitis epidemic in the 1980s, allowed these important results to be obtained.”

BioCubaFarma has described the progress made in the urgent effort to develop a vaccine here as a tribute to Comandante en Jefe Fidel Castro Ruz, visionary founder and promoter of the sector, while taking healthy pride in the results achieved, called on the entire population to maintain rigorous implementation of preventative measures to contain the epidemic as the country draws closer to producing our own vaccine.

Source: BERNAMA

Adib Mohd

Recent Posts

Sunway Lagoon Unleashes ‘The Wild Chase’, Malaysia’s First Hybrid Water Coaster

Malaysia’s favourite theme park is turning up the thrill dial with the launch of its… Read More

1 hour ago

The LEGO® Group And Netflix Launch A Treasure Trove Of ONE PIECE Sets

The LEGO Group, together with Netflix and Tomorrow Studios, set sail for new adventures with… Read More

3 hours ago

Magical Night Under the Big Top: Elmina Lakeside Mall Celebrates 1st Anniversary with Swiss Dream Circus Gala

Elmina Lakeside Mall has officially turned one, and what better way to mark the occasion… Read More

4 hours ago

Skechers Friendship Walk 2025, First Time in Setia Alam, & It’s Bigger Than Ever

Malaysia’s most feel-good fitness event is back and it’s gearing up to be the biggest… Read More

4 hours ago

Meet Lee Jun Young Up Close in Kuala Lumpur, Tickets Now Available

Malaysian fans, the wait is finally over! Lee Jun Young, the multitalented actor, singer and… Read More

3 days ago

Lee Jung-jae and Lim Ji-yeon Reignite the Rom-Com Spark in Nice to Not Meet You, Exclusively on Prime Video

Prime Video has unveiled Nice to Not Meet You, an upcoming Korean rom-com series starring… Read More

3 days ago

This website uses cookies.